These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35817738)

  • 21. Oxytocin Administration in High-Intensity Focused Ultrasound Treatment of Myomata.
    Lozinski T; Filipowska J; Krol P; Kubaty A; Wegrzyn P
    Biomed Res Int; 2018; 2018():7518026. PubMed ID: 30057909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in anti-müllerian hormone levels as a biomarker for ovarian reserve after ultrasound-guided high-intensity focused ultrasound treatment of adenomyosis and uterine fibroid.
    Lee JS; Hong GY; Lee KH; Kim TE
    BJOG; 2017 Aug; 124 Suppl 3():18-22. PubMed ID: 28856867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of magnetic resonance-guided high-intensity focused ultrasound with uterine artery embolization for the treatment of uterine myoma: A systematic literature review and meta-analysis.
    Jeng CJ; Long CY; Chuang LT
    Taiwan J Obstet Gynecol; 2020 Sep; 59(5):691-697. PubMed ID: 32917320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting the efficacy of high-intensity focused ultrasound (HIFU) ablation for uterine leiomyomas based on DTI indicators and imaging features.
    Qin SZ; Jiang Y; Wang YL; Liu N; Lin ZY; Jia Q; Fang J; Huang XH
    Abdom Radiol (NY); 2024 Jun; 49(6):2017-2026. PubMed ID: 36912910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of a microbubble ultrasound contrast agent on high-intensity focused ultrasound for uterine fibroids: a randomised controlled trial.
    Chen Y; Jiang J; Zeng Y; Tian X; Zhang M; Wu H; Zhou H
    Int J Hyperthermia; 2018 Dec; 34(8):1311-1315. PubMed ID: 29301450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pretreatment bowel manipulation during ultrasound-guided high-intensity focused ultrasound therapy for posterior wall uterine masses.
    Wu MH; Zhang Y; Chen D; Zhou N; Li H; Peng L; Huang MS; Kuo TC
    Taiwan J Obstet Gynecol; 2021 Nov; 60(6):1078-1083. PubMed ID: 34794741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preliminary study on ultrasound-guided high-intensity focused ultrasound ablation for treatment of broad ligament uterine fibroids.
    Wang Y; Xu Y; Wong F; Wang Y; Cheng Y; Yang L
    Int J Hyperthermia; 2021 Sep; 38(2):18-23. PubMed ID: 34420440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Volumetric feedback ablation of uterine fibroids using magnetic resonance-guided high intensity focused ultrasound therapy.
    Voogt MJ; Trillaud H; Kim YS; Mali WP; Barkhausen J; Bartels LW; Deckers R; Frulio N; Rhim H; Lim HK; Eckey T; Nieminen HJ; Mougenot C; Keserci B; Soini J; Vaara T; Köhler MO; Sokka S; van den Bosch MA
    Eur Radiol; 2012 Feb; 22(2):411-7. PubMed ID: 21901565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uterine fibroids: Influence of "T2-Rim sign" on immediate therapeutic responses to magnetic resonance imaging-guided high-intensity focused ultrasound ablation.
    Yeo SY; Kim YS; Lim HK; Rhim H; Jung SH; Hwang NY
    Eur J Radiol; 2017 Dec; 97():21-30. PubMed ID: 29153363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of dexmedetomidine-remifentanil in high-intensity ultrasound ablation of uterine fibroids: a randomised study.
    Fu X; Huang F; Chen Y; Deng Y; Wang Z
    BJOG; 2017 Aug; 124 Suppl 3():23-29. PubMed ID: 28856857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of sonographically guided high-intensity focused ultrasound for symptomatic uterine fibroids: preliminary study of a modified protocol.
    Leung JH; Yu SC; Cheung EC; Wong AS; Tong MM; Ho SS; Leung VY; Ahuja AT
    J Ultrasound Med; 2014 Oct; 33(10):1811-8. PubMed ID: 25253828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome of uterine artery embolization versus MR-guided high-intensity focused ultrasound treatment for uterine fibroids: long-term results.
    Froeling V; Meckelburg K; Schreiter NF; Scheurig-Muenkler C; Kamp J; Maurer MH; Beck A; Hamm B; Kroencke TJ
    Eur J Radiol; 2013 Dec; 82(12):2265-9. PubMed ID: 24075785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of biological characteristics of different types of uterine fibroids, as assessed with T2-weighted magnetic resonance imaging, on ultrasound-guided high-intensity focused ultrasound ablation.
    Zhao WP; Chen JY; Chen WZ
    Ultrasound Med Biol; 2015 Feb; 41(2):423-31. PubMed ID: 25542494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and clinical evaluation of a 3-step modified manipulation protocol for MRI-guided high-intensity focused ultrasound of uterine fibroids.
    Verpalen IM; van 't Veer-Ten Kate M; de Boer E; van den Hoed RD; Schutte JM; Dijkstra JR; Franx A; Bartels LW; Moonen CTW; Boomsma MF
    Eur Radiol; 2020 Jul; 30(7):3869-3878. PubMed ID: 32166489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preservation of the endometrial enhancement after magnetic resonance imaging-guided high-intensity focused ultrasound ablation of submucosal uterine fibroids.
    Kim YS; Kim TJ; Lim HK; Rhim H; Jung SH; Ahn JH; Lee JW; Kim BG
    Eur Radiol; 2017 Sep; 27(9):3956-3965. PubMed ID: 28210800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uterine Artery Embolization Compared with High-intensity Focused Ultrasound Ablation for the Treatment of Symptomatic Uterine Myomas: A Systematic Review and Meta-analysis.
    Liu L; Wang T; Lei B
    J Minim Invasive Gynecol; 2021 Feb; 28(2):218-227. PubMed ID: 33197612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mid-term clinical efficacy of a volumetric magnetic resonance-guided high-intensity focused ultrasound technique for treatment of symptomatic uterine fibroids.
    Ikink ME; Voogt MJ; Verkooijen HM; Lohle PN; Schweitzer KJ; Franx A; Mali WP; Bartels LW; van den Bosch MA
    Eur Radiol; 2013 Nov; 23(11):3054-61. PubMed ID: 23793518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility of the novel vascular disrupting agent C118P for facilitating high-intensity focused ultrasound ablation of uterine fibroids.
    Li Y; Zhang J; Lu C; Guo M; Zhang J; Huang G; Ni Y; Chen Y
    Int J Hyperthermia; 2023; 40(1):2185576. PubMed ID: 36913972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility, Safety, and Efficacy of Accurate Uterine Fibroid Ablation Using Magnetic Resonance Imaging-Guided High-Intensity Focused Ultrasound With Shot Sonication.
    Xu Y; Fu Z; Yang L; Huang Z; Chen WZ; Wang Z
    J Ultrasound Med; 2015 Dec; 34(12):2293-303. PubMed ID: 26518278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histological findings in resected leiomyomas following MR-HIFU treatment, single-institution data from seven patients with unfavorable focal therapy.
    Viitala A; Gabriel M; Joronen K; Komar G; Perheentupa A; Sainio T; Huvila J; Pikander P; Taimen P; Blanco Sequeiros R
    Int J Hyperthermia; 2023; 40(1):2234666. PubMed ID: 37487574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.